Maestros Mediline Systems Ltd - Stock Valuation and Financial Performance

BSE: 501209 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Maestros MedilineSys

M-Cap below 100cr DeciZen not available

Maestros Mediline Systems stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
4.6 Cr.
52-wk low:
10.4
52-wk high:
10.4

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Maestros MedilineSys:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
ROCE % 2.9%5.6%3.5%4%10.2%9.1%-20.5%-29.9%-80%-18.5%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2533.827.628.139.132.39.874.20.61
Sales YoY Gr.-34.9%-18.3%2%38.8%-17.4%-69.6%-28.5%-39.7%-86.8%-
Adj EPS 1.52.80.50.26.24.3-33.2-31.5-51-6.9-6.9
YoY Gr.-92.5%-83.6%-58.7%3152.6%-30.3%-870.3%NANANA-
BVPS (₹) 7578.480.481.687.637.14.1-29.4-82.2-89-33.5
Adj Net
Profit
0.71.30.20.12.71.9-14.5-13.8-22.3-3-3
Cash Flow from Ops. -4.213.37.33.32.6-5.9-9.50.5-0.30-
Debt/CF from Ops. -2.50.31.12.34.5-6.3-5.2104.4-200.71650.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -34.4%-57.2%-61.5%-86.8%
Adj EPS -218.8%-202.1%NANA
BVPS-201.9%-200.3%-378.7%NA
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16TTM
Return on
Equity %
1.93.60.60.27.36.9-161.2249.191.4811.2
Op. Profit
Mgn %
13.312.712.712.718.922.7-93.1-171.4-509-433.6-33
Net Profit
Mgn %
2.73.80.70.36.95.8-147.8-196.2-527.3-539-536.1
Debt to
Equity
0.30.10.20.20.32.327.6-4-1.5-1.4-
Working Cap
Days
3893303854043224651,8682,5882,2946,077904
Cash Conv.
Cycle
1831511681431252101,0701,3341,0551,22568

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Maestros Mediline Systems Ltd.

Standalone Consolidated
TTM EPS (₹) -6.9 -6.9
TTM Sales (₹ Cr.) 0.6 0.6
BVPS (₹.) -33.5 -91.7
Reserves (₹ Cr.) -19 -44
P/BV -0.31 -0.11
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 10.44 / 10.44
All Time Low / High (₹) 3.50 / 81.75
Market Cap (₹ Cr.) 4.6
Equity (₹ Cr.) 4.4
Face Value (₹) 10
Industry PE 56.4

Management X-Ray of Maestros MedilineSys:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *57.370.000.0057.3756.4556.4556.4556.4556.4556.45
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Maestros MedilineSys

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Sales25.0233.7627.5928.1439.0632.269.827.024.230.56
Operating Expenses 21.8329.5124.1024.5731.9824.9318.9720.3125.742.97
Manufacturing Costs0.730.720.590.590.650.370.570.320.110.17
Material Costs13.2619.0912.5013.3719.9812.0410.0212.975.180.79
Employee Cost 3.764.675.595.826.327.065.833.121.641.60
Other Costs 4.075.035.424.805.035.462.553.8918.810.41
Operating Profit 3.204.253.493.577.087.33-9.15-13.29-21.51-2.42
Operating Profit Margin (%) 12.8%12.6%12.6%12.7%18.1%22.7%-93.1%-189.0%-509.0%-433.0%
Other Income 0.080.280.590.950.800.220.750.170.040.14
Interest 0.791.591.832.392.9445.380.550.030.02
Depreciation 1.761.261.241.732.341.811.8810.790.70
Exceptional Items 0000000000
Profit Before Tax 0.721.6810.402.601.74-15.66-14.66-22.29-3
Tax 0.150.430.800.180.10-0.14-1.25000
Profit After Tax 0.571.250.200.222.501.88-14.41-14.66-22.29-3
PAT Margin (%) 2.3%3.7%0.7%0.8%6.4%5.8%-146.0%-208.0%-527.0%-538.0%
Adjusted EPS (₹)1.32.70.50.55.74.3-33.0-33.5-51.0-6.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16

Equity and Liabilities

Shareholders Fund 34.9336.1835.7935.8138.3116.211.80-12.86-35.93-38.93
Share Capital 4.554.554.424.374.374.374.374.374.374.37
Reserves 30.3831.6331.3831.4433.9411.84-2.58-17.23-40.30-43.30
Minority Interest0000000000
Debt10.474.397.797.5011.7337.0849.6251.0453.4053.67
Long Term Debt10.474.397.797.503.5522.8729.9330.0129.8829.94
Short Term Debt00008.1814.2119.6921.0423.5123.73
Trade Payables4.155.996.038.858.019.66108.911.513.33
Others Liabilities 10.4112.5417.3316.8515.729.5813.0610.743.884.34
Total Liabilities 59.9659.1066.936973.7772.5474.4757.8322.8622.42

Fixed Assets

Gross Block30.5231.4437.5539.4644.7523.9725.0117.7716.9916.99
Accumulated Depreciation7.498.349.5711.3113.628.7410.624.325.105.80
Net Fixed Assets23.0323.1027.9728.1631.1315.2314.3913.4511.8811.19
CWIP 0.340.180.36007.400000
Investments 0.314.611.031.031.540.730.730.010.010.01
Inventories7.928.408.0910.3113.0113.6612.132.390.570.15
Trade Receivables11.1414.1110.6911.7113.5121.1122.39252.561.87
Cash Equivalents 1.331.737.426.284.133.780.991.270.520.70
Others Assets15.896.9811.3711.5210.4510.6223.8415.717.328.49
Total Assets 59.9659.1066.936973.7772.5474.4757.8322.8622.42

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Cash Flow From Operating Activity -4.1913.347.283.282.59-5.93-9.510.49-0.270.03
PBT 0.721.6810.402.601.74-15.66-14.66-22.29-3
Adjustment 3.012.933.204.265.405.816.703.7619.140.66
Changes in Working Capital -7.918.733.09-1.37-5.42-13.48-0.5511.392.882.37
Tax Paid 0000000000
Cash Flow From Investing Activity -1.02-5.46-2.57-1.54-5.83-14.55-1.570.42-0.380.11
Capex 0.040.02000.0200000
Net Investments 0.07-4.303.580000000
Others -1.13-1.19-6.15-1.54-5.86-14.55-1.570.42-0.380.11
Cash Flow From Financing Activity 5.80-7.480.98-2.881.2921.967.50-0.26-0.140.04
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 6.56-6.08004.2300000
Interest Paid -0.76-1.39-1.83-2.39-2.94-40000
Dividend Paid 0000000000
Others 002.82-0.49025.967.50-0.26-0.140.04
Net Cash Flow 0.600.405.69-1.14-1.951.48-3.590.65-0.790.18
PARTICULARSMar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16
Ratios
ROE (%)1.693.580.560.616.766.91-160.07N/AN/AN/A
ROCE (%)3.717.726.86.4311.8811.11-19.63N/AN/AN/A
Asset Turnover Ratio0.480.590.440.420.560.440.140.110.110.03
PAT to CFO Conversion(x)-7.3510.6736.414.911.04-3.15N/AN/AN/AN/A
Working Capital Days
Receivable Days1381321621431161967831,2091,1811,285
Inventory Days10885108117107151464370127209
Payable Days98971752031542683582663671,121

Maestros Mediline Systems Ltd Stock News

Maestros Mediline Systems Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Maestros MedilineSys on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Maestros MedilineSys stood at ₹4.57.
The latest P/E ratio of Maestros MedilineSys as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Maestros MedilineSys as of 01-Jan-1970 05:30 is -0.31.
The 52-week high of Maestros MedilineSys is ₹10.44 and the 52-week low is ₹10.44.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Maestros MedilineSys is ₹0.56 ( Cr.) .

About Maestros Mediline Systems Ltd

Maestros Mediline Systems Ltd. ever since its beginning in 1992 has carved a niche in competitive fields of cardiological & gynecological equipment. The company has 10 offices across the sub-continent and about 200+ employees to provide prompt sales & support to customers.They have their manufacturing works at Navi Mumbai (Maharashtra) and Parwanoo (Himachal Pradesh).

All their products are delicately planned, designed and developed with combined dedicated efforts by their team that includes biomedical engineers, designers, doctors and other expertise to bring forth the latest technology.They also proudly acknowledge that they have designed, developed and launched recently, state-of-the-art telemedicine products like complete telemedicine software, event recorders, telemedicine peripherals etc.

Maestros has installed its equipment throughout the length & breadth of the sub-continent by many World Bank assisted State Health Systems Development Projects (Punjab Health Systems Corporation, Orissa Health Systems Development Project, Uttar Pradesh Health Systems Development Project, Maharashtra Health Systems Development Project, Kerala Health Systems Development etc). These World Bank assisted orders and distinguished private institutions / Government bodies have further motivated Maestros vision to become a globally renowned organization and continue designing World Class equipment.

On its focus to go global, Maestros has already started their distinct network in Far East / Middle East / Egypt and already has 500+ installations outside India in a short span of 1 year.

Product range of the company includes:

Cardiology

  • ECG Recorders  
  • Stress Test System   
  • Spirometers  
  • Defibrillator

Gynecology

  • Portable Fetal Monitors
  • Monitoring
  • Pulse Oximeters 
  • Patient Monitors 
  • Central Monitoring Station

Ultrasound

  • Sonomagic

Infusion Pump

Syringe Pump

Telemedicine

Milestones:

  • 1992   Maestros started its operations in medical electronics in Juhu, a suburb in Mumbai. 
  • 1993   Moved to new premises at Neelam Center, Worli. Established the company as a value-added professional with Sonata.
  • 1994   Became the third solution provider to Microsoft in India.
  • 1995   Started Training operations and became the Authorized Training Center for Microsoft.
  • 1996   Became a Support Center for Microsoft and moved into Consultancy.
  • 1997   Expanded the distribution network for the Medical Electronics Division. Started operations at Bangalore and Pune
  • 1998   Converted into a Public company. Formed the corporate office in Mumbai and established a zonal office in Bangalore.
  • 1999   Acquired the IEC 601 certification for Medical Embedded Systems. Built up a factory structure for Medical Embedded Systems for full fledged production activity. Opened a branch office in Pune.
  • 2000   Opened a zonal office in Delhi. Started operations in Ahmedabad, Bhopal, Lucknow, Chandigarh and Cochin.
  • 2001   Acquired additional premises at Silvassa for enhancing production activities. Obtained the ISO 9001:2000 accreditation from Bureau Veritas Quality International. Opened a branch office at Lucknow and Hyderabad.
  • 2002   Started Eastern zone operations. Started additional manufacturing unit at Silvassa (Gujarat).
  • 2003   Registered with Bombay Stock Exchange.
  • 2004   Initiated export operations in South East Asia & Middle East.
  • 2005   Started factory in Parwanoo, Himachal Pradesh. Obtained ISO 13485:2003 from Orion Registrar, Inc. CE mark for ECG machine. Introduced Telemedicine products and software.
  • 2006   Expanded existing manufacturing unit in Mahape, Navi Mumbai for manufacturing and R&D activities. Introduced Embedded Systems & executed projects for corporates.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.